Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4740)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2013 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rigopoulou EI, Zachou K, Gatselis NK, Papadamou G, Koukoulis GK, Dalekos GN. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcome. World J Hepatol 2013; 5(10): 577-583 [PMID: PMC3812460 DOI: 10.4254/wjh.v5.i10.577] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i10/577.htm |
| Number | Citing Articles |
| 1 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Shirokova. Immune disorders and rheumatologic manifestations of viral hepatitis. World Journal of Gastroenterology 2021; 27(18): 2073-2089 doi: 10.3748/wjg.v27.i18.2073
|
| 2 |
Balázs Nemes, György Gámán, Attila Doros. Biliary complications after liver transplantation. Expert Review of Gastroenterology & Hepatology 2015; 9(4): 447 doi: 10.1586/17474124.2015.967761
|
| 3 |
Tatsuo Kanda, Shin Yasui, Masato Nakamura, Shingo Nakamoto, Koji Takahashi, Shuang Wu, Reina Sasaki, Yuki Haga, Sadahisa Ogasawara, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Yoshihiko Ooka, Eiichiro Suzuki, Tetsuhiro Chiba, Hitoshi Maruyama, Fumio Imazeki, Mitsuhiko Moriyama, Naoya Kato. Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget 2018; 9(14): 11631 doi: 10.18632/oncotarget.24391
|
| 4 |
Satoshi Takakusagi, Hitoshi Takagi, Yozo Yokoyama, Kyoko Marubashi, Kazuko Kizawa, Takashi Kosone, Ken Sato, Satoru Kakizaki, Toshio Uraoka. Successful treatment with glecaprevir/pibrentasvir for chronic hepatitis C complicated by primary biliary cholangitis. Clinical Journal of Gastroenterology 2020; 13(5): 896 doi: 10.1007/s12328-020-01103-w
|
| 5 |
Ying-Qiu Huang. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World Journal of Hepatology 2016; 8(33): 1419-1441 doi: 10.4254/wjh.v8.i33.1419
|
| 6 |
George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou, George K. Koukoulis. NAFLD and autoimmune hepatitis: Do not judge a book by its cover. European Journal of Internal Medicine 2020; 75: 1 doi: 10.1016/j.ejim.2020.02.001
|
| 7 |
Panagiotis A. Papamichalis, Kalliopi Zachou, Roidoula A. Papamichali, Maria Ioannou, Nikolaos K. Gatselis, George N. Dalekos, George K. Koukoulis. Promyelocytic leukemia antigen expression: A histological marker for primary biliary cholangitis diagnosis?. Journal of Translational Internal Medicine 2021; 9(1): 43 doi: 10.2478/jtim-2021-0008
|
| 8 |
Ron Nudel, Rosa Lundbye Allesøe, Wesley K. Thompson, Thomas Werge, Simon Rasmussen, Michael E. Benros. A large-scale investigation into the role of classical HLA loci in multiple types of severe infections, with a focus on overlaps with autoimmune and mental disorders. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02888-1
|
| 9 |
Daniel Zahner, Hannah Glimm, Tomomitsu Matono, Yuri Churin, Diran Herebian, Ertan Mayatepek, Kernt Köhler, Stefan Gattenlöhner, Anne Stinn, Annette Tschuschner, Martin Roderfeld, Elke Roeb. Hepatitis B virus surface proteins accelerate cholestatic injury and tumor progression in Abcb4-knockout mice. Oncotarget 2017; 8(32): 52560 doi: 10.18632/oncotarget.15003
|
| 10 |
Karuna Irungbam, Martin Roderfeld, Hannah Glimm, Felix Hempel, Franziska Schneider, Laura Hehr, Dieter Glebe, Yuri Churin, Gertrud Morlock, Imanuel Yüce, Elke Roeb. Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic mice. Laboratory Investigation 2020; 100(11): 1411 doi: 10.1038/s41374-020-0457-9
|
| 11 |
Eirini I. Rigopoulou, George N. Dalekos. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers 2021; 13(5): 1023 doi: 10.3390/cancers13051023
|
| 12 |
Maria Rendina, Nicola Maurizio Castellaneta, Giuseppe Losurdo, Antonino Castellaneta, Annamaria Cazzolla, Claudia Chialà, Francesca D’Errico, Alfredo Di Leo. Primary biliary cholangitis triggered by DAAs-induced HCV clearance: a biological proof of concept. Therapeutic Advances in Chronic Disease 2018; 9(6): 121 doi: 10.1177/2040622318755651
|
| 13 |
Yun Ye, Qian Zhang, Zhong-Hua Lu, You-Wen Tan. Clinicopathological features of 11 cases of chronic hepatitis B infection complicated with primary biliary cholangitis. World Journal of Hepatology 2023; 15(4): 577-584 doi: 10.4254/wjh.v15.i4.577
|
| 14 |
Eirini I Rigopoulou, Dimitrios P Bogdanos. Role of autoantibodies in the clinical management of primary biliary cholangitis. World Journal of Gastroenterology 2023; 29(12): 1795-1810 doi: 10.3748/wjg.v29.i12.1795
|
| 15 |
Asad Javaid, Mugilan Poongkunran, Felicia D. Allard, Win Kyaw, Htet Htet Maung, Daryl Lau. Subtle presentation of active primary biliary cirrhosis in chronic hepatitis B: a case report. Gastroenterology Report 2016; : gov064 doi: 10.1093/gastro/gov064
|
| 16 |
George N. Dalekos, Nikolaos K. Gatselis. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases. Archivum Immunologiae et Therapiae Experimentalis 2019; 67(4): 197 doi: 10.1007/s00005-019-00550-9
|
| 17 |
Yu-Chan Chang, Ming-Huang Chen, Chun-Nan Yeh, Michael Hsiao. Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma. Biomolecules 2020; 10(10): 1377 doi: 10.3390/biom10101377
|